ATA77095A - Stabiles präparat zur behandlung von blutgerinnungsstörungen, enthaltend eine aktive gerinnungsfördernde stubstanz - Google Patents
Stabiles präparat zur behandlung von blutgerinnungsstörungen, enthaltend eine aktive gerinnungsfördernde stubstanzInfo
- Publication number
- ATA77095A ATA77095A AT0077095A AT77095A ATA77095A AT A77095 A ATA77095 A AT A77095A AT 0077095 A AT0077095 A AT 0077095A AT 77095 A AT77095 A AT 77095A AT A77095 A ATA77095 A AT A77095A
- Authority
- AT
- Austria
- Prior art keywords
- coagning
- disorders
- blood
- treatment
- stable preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4866—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21006—Coagulation factor Xa (3.4.21.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4416180A DE4416180C2 (de) | 1994-05-06 | 1994-05-06 | Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen und Verfahren zur Herstellung dieses Präparats |
Publications (1)
Publication Number | Publication Date |
---|---|
ATA77095A true ATA77095A (de) | 2002-04-15 |
Family
ID=6517576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0077095A ATA77095A (de) | 1994-05-06 | 1995-05-05 | Stabiles präparat zur behandlung von blutgerinnungsstörungen, enthaltend eine aktive gerinnungsfördernde stubstanz |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0680763A3 (de) |
JP (1) | JPH0840928A (de) |
AT (1) | ATA77095A (de) |
CA (1) | CA2148672A1 (de) |
DE (1) | DE4416180C2 (de) |
FI (1) | FI952170A (de) |
NO (1) | NO951762L (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4416166C2 (de) * | 1994-05-06 | 1997-11-20 | Immuno Ag | Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen |
DE59712322D1 (de) * | 1996-03-20 | 2005-06-30 | Baxter Ag | Pharmazeutisches Präparat zur Behandlung von Blutgerinnungsstörungen |
WO1999066939A1 (en) * | 1998-06-23 | 1999-12-29 | Marder Victor J | Phospholipid vesicle-tissue factor complex preparations and methods of making and using same |
US7056529B2 (en) * | 2002-05-14 | 2006-06-06 | University Of Louisville Research Foundation, Inc. | Direct cellular energy delivery system |
WO2007117469A2 (en) | 2006-03-30 | 2007-10-18 | The Research Foundation Of State University Of New York | Compositions of less immunogenic and long-circulating protein-lipid complexes |
US10538754B2 (en) | 2015-02-06 | 2020-01-21 | Omrix Biopharmaceuticals Ltd. | Method for preparation of thrombin |
US20220096707A1 (en) * | 2018-10-17 | 2022-03-31 | Toray Industries, Inc. | Hemostatic material |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4348384A (en) * | 1980-10-17 | 1982-09-07 | Dainippon Pharmaceutical Co., Ltd. | Pharmaceutical composition for oral administration containing coagulation factor VIII or IX |
JPS5770814A (en) * | 1980-10-17 | 1982-05-01 | Isamu Horikoshi | Oral preparation of blood clotting eighth factor |
GB2129685B (en) * | 1982-11-11 | 1985-11-13 | Nat Biolog Standards Board | Anti-haemophilic compositions |
US4610880A (en) * | 1983-06-27 | 1986-09-09 | Queen's University At Kingston | Composition for controlling hemophilia in mammals |
US4721618A (en) * | 1983-06-27 | 1988-01-26 | Queen's University At Kingston | Method for controlling bleeding |
AT389815B (de) * | 1984-03-09 | 1990-02-12 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten |
WO1990003808A1 (en) * | 1988-10-07 | 1990-04-19 | The Liposome Company, Inc. | Heat treating liposomes |
AU5959990A (en) * | 1989-08-14 | 1991-04-03 | Queen's University At Kingston | Method for stimulating fibrinolytic effect |
US5504064A (en) * | 1991-04-10 | 1996-04-02 | Oklahoma Medical Research Foundation | Treatment of bleeding with modified tissue factor in combination with an activator of FVII |
DE69418334T2 (de) * | 1993-08-06 | 2000-01-27 | Opperbas Holding B.V., Amsterdam | Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen |
DE4416166C2 (de) * | 1994-05-06 | 1997-11-20 | Immuno Ag | Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen |
-
1994
- 1994-05-06 DE DE4416180A patent/DE4416180C2/de not_active Expired - Fee Related
-
1995
- 1995-05-04 CA CA002148672A patent/CA2148672A1/en not_active Abandoned
- 1995-05-05 EP EP95106815A patent/EP0680763A3/de not_active Withdrawn
- 1995-05-05 AT AT0077095A patent/ATA77095A/de not_active Application Discontinuation
- 1995-05-05 NO NO951762A patent/NO951762L/no unknown
- 1995-05-05 FI FI952170A patent/FI952170A/fi unknown
- 1995-05-08 JP JP7109453A patent/JPH0840928A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0680763A3 (de) | 1998-01-28 |
DE4416180C2 (de) | 1997-08-14 |
DE4416180A1 (de) | 1995-11-09 |
NO951762D0 (no) | 1995-05-05 |
NO951762L (no) | 1995-11-07 |
FI952170A (fi) | 1995-11-07 |
CA2148672A1 (en) | 1995-11-07 |
EP0680763A2 (de) | 1995-11-08 |
FI952170A0 (fi) | 1995-05-05 |
JPH0840928A (ja) | 1996-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA76995A (de) | Stabiles präparat zur behandlung von blutgerinnungsstörungen | |
DE69929996D1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
DE69022249D1 (de) | Knochenwachsapplikator zur Behandlung von Knochengewebe. | |
DE60043305D1 (de) | Pharmazeutische zubereitungen zur behandlung von insulinresitenz | |
DE69227883D1 (de) | Riechstoffmikrokapseln zur Behandlung von Wäsche | |
DE69710095D1 (de) | Pharmazeutische zubereitung zur behandlung von diabetes | |
DE3772429D1 (de) | Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten. | |
DE3685633D1 (de) | Behandlung von knochenstoerungen. | |
DE69018043D1 (de) | Behandlung von Geflügel. | |
DE50010284D1 (de) | Arzneimittel zur behandlung von bluthochdruck | |
DE3782214D1 (de) | Mittel zur behandlung des scheidenmilieus. | |
DE69600983D1 (de) | Kapselpräparate zur Behandlung von Pflanzen | |
DE69727240D1 (de) | Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv | |
DE69829217D1 (de) | Vorrichtung zur therapeutischen behandlung von blutgefässen | |
ATA77095A (de) | Stabiles präparat zur behandlung von blutgerinnungsstörungen, enthaltend eine aktive gerinnungsfördernde stubstanz | |
ATE264309T1 (de) | Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren | |
DE69735417D1 (de) | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen | |
ATA113492A (de) | Mehrfachbeutelsystem zur sterilen behandlung von menschlichen blutkonserven | |
DE3777779D1 (de) | Behandlung des haares. | |
DE3674321D1 (de) | Behandlung geschmeidiger gewebe. | |
DE68901172D1 (de) | (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend. | |
DE69813354D1 (de) | Mittel zur Behandlung von Herzkrankheiten | |
ATA159597A (de) | Präparat zur behandlung von blutgerinnungsstörungen | |
DE3668338D1 (de) | Kontinuierliche behandlung von spannungslosem gewebe. | |
DE60009069D1 (de) | Bispidin-derivate zur behandlung von herzarrhythmien |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1J | Withdrawal paragraph 166 lit. 6 |